Eton Pharmaceuticals, Inc. (ETON) Free cash flow 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$10.2MFY2025 · since FY2018: -$8.4M → $10.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.2M | +980.7% |
| FY2024 | $943,000 | -86.2% |
| FY2023 | $6.8M | +42.5% |
| FY2022 | $4.8M | +201.1% |
| FY2021 | -$4.7M | +78.9% |
| FY2020 | -$22.4M | -17.1% |
| FY2019 | -$19.1M | -128.2% |
| FY2018 | -$8.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice